Sumoylation in synaptic function and dysfunction

Frontiers in Synaptic Neuroscience

Volumn 8, Issue APR, 2016, Pages

  Schorova, Lenka ^a   Martin, Stéphane ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Desumoylation; Post translational modification; SUMO; Sumoylation; Synapse

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT SERINE PROTEIN KINASE; CANNABINOID 1 RECEPTOR; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DJ 1 PROTEIN; HUNTINGTIN; KAINIC ACID RECEPTOR; LA ANTIGEN; METABOTROPIC RECEPTOR; METHYL CPG BINDING PROTEIN 2; MYOCYTE ENHANCER FACTOR 2; PARKIN; PHOSPHOPROTEIN; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; PROTEIN SERINE THREONINE KINASE; RAB3 INTERACTING MOLECULE 1ALPHA; SHAB POTASSIUM CHANNEL; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO PROTEIN; SYNAPSIN IA; SYNAPTOTAGMIN I; SYNTAXIN 1A; TAU PROTEIN; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; CELL MATURATION; DOWN SYNDROME; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; POSTSYNAPTIC MEMBRANE; REVIEW; SUMOYLATION; SYNAPSE; SYNAPTOGENESIS;

EID: 84993990154     PISSN: None     EISSN: 16633563     Source Type: Journal    
DOI: 10.3389/fnsyn.2016.00009     Document Type: Review

References (184)

1. Ahn, K., Song, J. H., Kim, D. K., Park, M. H., Jo, S. A., and Koh, Y. H. (2009). Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study. Neurosci. Lett. 465, 272-275. doi: 10.1016/j.neulet.2009.09.017
2. Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., and Deutsch, S. (2004). Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat. Rev. Genet. 5, 725-738. doi: 10.1038/nrg1448
3. Bayfield, M. A., Yang, R., and Maraia, R. J. (2010). Conserved and divergent features of the structure and function of La and La-related proteins (LARPs). Biochim. Biophys. Acta 1799, 365-378. doi: 10.1016/j.bbagrm.2010.01.011
4. Bell, K. F., Bent, R. J., Meese-Tamuri, S., Ali, A., Forder, J. P., and Aarts, M. M. (2013). Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption. J. Neurochem. 126, 274-287. doi: 10.1111/jnc.12176
5. Berg, J. S., Brunetti-Pierri, N., Peters, S. U., Kang, S. H., Fong, C. T., Salamone, J., et al. (2007). Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet. Med. 9, 427-441. doi: 10.1097/gim.0b013e3180986192
6. Bernier-Villamor, V., Sampson, D. A., Matunis, M. J., and Lima, C. D. (2002). Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108, 345-356. doi: 10.1016/s0092-8674(02)00630-x
7. Bingol, B., and Schuman, E. M. (2006). Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 441, 1144-1148. doi: 10.1038/nature04769
8. Bohren, K. M., Nadkarni, V., Song, J. H., Gabbay, K. H., and Owerbach, D. (2004). A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279, 27233-27238. doi: 10.1074/jbc.m402273200
9. Bramham, C. R., Alme, M. N., Bittins, M., Kuipers, S. D., Nair, R. R., Pai, B., et al. (2010). The Arc of synaptic memory. Exp. Brain Res. 200, 125-140. doi: 10.1007/s00221-009-1959-2
10. Brandon, N. J., and Sawa, A. (2011). Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 12, 707-722. doi: 10.1038/nrn3120
11. Brenet, F., Socci, N. D., Sonenberg, N., and Holland, E. C. (2009). Akt phosphorylation of La regulates specific mRNA translation in glial progenitors. Oncogene 28, 128-139. doi: 10.1038/onc.2008.376
12. Brittain, J. M., Duarte, D. B., Wilson, S. M., Zhu, W., Ballard, C., Johnson, P. L., et al. (2011). Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complex. Nat. Med. 17, 822-829. doi: 10.1038/nm.2345
13. Broekhuis, C. H., Neubauer, G., van der Heijden, A., Mann, M., Proud, C. G., van Venrooij, W. J., et al. (2000). Detailed analysis of the phosphorylation of the human La (SS-B) autoantigen. (De)phosphorylation does not affect its subcellular distribution. Biochemistry 39, 3023-3033. doi: 10.1021/bi992308c
14. Calakos, N., Schoch, S., Südhof, T. C., and Malenka, R. C. (2004). Multiple roles for the active zone protein RIM1a in late stages of neurotransmitter release. Neuron 42, 889-896. doi: 10.1016/j.neuron.2004.05.014
15. Calo, L., Wegrzynowicz, M., Santivañez-Perez, J., and Grazia Spillantini, M. (2016). Synaptic failure and a-synuclein. Mov. Disord. 31, 169-177. doi: 10.1002/mds.26479
16. Castillo, P. E., Schoch, S., Schmitz, F., Südhof, T. C., and Malenka, R. C. (2002). RIM1a is required for presynaptic long-term potentiation. Nature 415, 327-330. doi: 10.1038/415327a
17. Cesca, F., Baldelli, P., Valtorta, F., and Benfenati, F. (2010). The synapsins: key actors of synapse function and plasticity. Prog. Neurobiol. 91, 313-348. doi: 10.1016/j.pneurobio.2010.04.006
18. Chamberlain, S. E., González-González, I. M., Wilkinson, K. A., Konopacki, F. A., Kantamneni, S., Henley, J. M., et al. (2012). SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity. Nat. Neurosci. 15, 845-852. doi: 10.1038/nn.3089
19. Chao, H. W., Hong, C. J., Huang, T. N., Lin, Y. L., and Hsueh, Y. P. (2008). SUMOylation of the MAGUK protein CASK regulates dendritic spinogenesis. J. Cell Biol. 182, 141-155. doi: 10.1083/jcb.200712094
20. Chen, Y. C., Hsu, W. L., Ma, Y. L., Tai, D. J., and Lee, E. H. (2014). CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory. J. Neurosci. 34, 9574-9589. doi: 10.1523/JNEUROSCI.4302-13.2014
21. Cheng, J., Huang, M., Zhu, Y., Xin, Y. J., Zhao, Y. K., Huang, J., et al. (2014). SUMOylation of MeCP2 is essential for transcriptional repression and hippocampal synapse development. J. Neurochem. 128, 798-806. doi: 10.1111/jnc.12523
22. Choi, J. H., Park, J. Y., Park, S. P., Lee, H., Han, S., Park, K. H., et al. (2016). Regulation of mGluR7 trafficking by SUMOylation in neurons. Neuropharmacology 102, 229-235. doi: 10.1016/j.neuropharm.2015.11.021
23. Chowdhury, S., Shepherd, J. D., Okuno, H., Lyford, G., Petralia, R. S., Plath, N., et al. (2006). Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52, 445-459. doi: 10.1016/j.neuron.2006.08.033
24. Cohen, S., and Greenberg, M. E. (2008). Communication between the synapse and the nucleus in neuronal development, plasticity and disease. Annu. Rev. Cell Dev. Biol. 24, 183-209. doi: 10.1146/annurev.cellbio.24.110707.175235
25. Contractor, A., Mulle, C., and Swanson, G. T. (2011). Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci. 34, 154-163. doi: 10.1016/j.tins.2010.12.002
26. Corneveaux, J. J., Myers, A. J., Allen, A. N., Pruzin, J. J., Ramirez, M., Engel, A., et al. (2010). Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet. 19, 3295-3301. doi: 10.1093/hmg/ddq221
27. Craig, T. J., Anderson, D., Evans, A. J., Girach, F., and Henley, J. M. (2015). SUMOylation of Syntaxin1A regulates presynaptic endocytosis. Sci. Rep. 5:17669. doi: 10.1038/srep17669
28. Craig, T. J., Jaafari, N., Petrovic, M. M., Rubin, P. P., Mellor, J. R., Henley, J. M., et al. (2012). Homeostatic synaptic scaling is regulated by protein SUMOylation. J. Biol. Chem. 287, 22781-22788. doi: 10.1074/jbc.m112.356337
29. Dai, X. Q., Kolic, J., Marchi, P., Sipione, S., and Macdonald, P. E. (2009). SUMOylation regulates Kv2.1 and modulates pancreatic β-cell excitability. J. Cell Sci. 122, 775-779. doi: 10.1242/jcs.036632
30. Dai, X. Q., Plummer, G., Casimir, M., Kang, Y., Hajmrle, C., Gaisano, H. Y., et al. (2011). SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Diabetes 60, 838-847. doi: 10.2337/db10-0440
31. De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., et al. (2007). Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590-11601. doi: 10.1074/jbc.m607483200
32. Depienne, C., Heron, D., Betancur, C., Benyahia, B., Trouillard, O., Bouteiller, D., et al. (2007). Autism, language delay and mental retardation in a patient with 7q11 duplication. J. Med. Genet. 44, 452-458. doi: 10.1136/jmg.2006.047092
33. DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., et al. (1995). Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081. doi: 10.1016/0896-6273(95)90346-1
34. Dodson, P. D., and Forsythe, I. D. (2004). Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability. Trends Neurosci. 27, 210-217. doi: 10.1016/j.tins.2004.02.012
35. Dorval, V., and Fraser, P. E. (2006). Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and a-synuclein. J. Biol. Chem. 281, 9919-9924. doi: 10.1074/jbc.m510127200
36. Dorval, V., and Fraser, P. E. (2007). SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 1773, 694-706. doi: 10.1016/j.bbamcr.2007.03.017
37. Dorval, V., Mazzella, M. J., Mathews, P. M., Hay, R. T., and Fraser, P. E. (2007). Modulation of Aβ generation by small ubiquitin-like modifiers does not require conjugation to target proteins. Biochem. J. 404, 309-316. doi: 10.1042/bj20061451
38. Drisaldi, B., Colnaghi, L., Fioriti, L., Rao, N., Myers, C., Snyder, A. M., et al. (2015). SUMOylation is an inhibitory constraint that regulates the prion-like aggregation and activity of CPEB3. Cell Rep. 11, 1694-1702. doi: 10.1016/j.celrep.2015.04.061
39. Dulubova, I., Lou, X., Lu, J., Huryeva, I., Alam, A., Schneggenburger, R., et al. (2005). A Munc13/RIM/Rab3 tripartite complex: from priming to plasticity? EMBO J. 24, 2839-2850. doi: 10.1038/sj.emboj.7600753
40. Dustrude, E. T., Wilson, S. M., Ju, W., Xiao, Y., and Khanna, R. (2013). CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking. J. Biol. Chem. 288, 24316-24331. doi: 10.1074/jbc.M113.474924
41. Dütting, E., Schröder-Kress, N., Sticht, H., and Enz, R. (2011). SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b. Biochem. J. 435, 365-371. doi: 10.1042/BJ20101854
42. Eckermann, K. (2013). SUMO and Parkinson's disease. Neuromolecular Med. 15, 737-759. doi: 10.1007/s12017-013-8259-5
43. Estruch, S. B., Graham, S. A., Deriziotis, P., and Fisher, S. E. (2016). The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers. Sci. Rep. 6:20911. doi: 10.1038/srep20911
44. Feligioni, M., Nishimune, A., and Henley, J. M. (2009). Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals. Eur. J. Neurosci. 29, 1348-1356. doi: 10.1111/j.1460-9568.2009.06692.x
45. Fioriti, L., Myers, C., Huang, Y. Y., Li, X., Stephan, J. S., Trifilieff, P., et al. (2015). The persistence of hippocampal-based memory requires protein synthesis mediated by the prion-like protein CPEB3. Neuron 86, 1433-1448. doi: 10.1016/j.neuron.2015.05.021
46. Flavell, S. W., and Greenberg, M. E. (2008). Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563-590. doi: 10.1146/annurev.neuro.31.060407.125631
47. Flavell, S. W., Cowan, C. W., Kim, T. K., Greer, P. L., Lin, Y., Paradis, S., et al. (2006). Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008-1012. doi: 10.1126/science.1122511
48. Flotho, A., and Melchior, F. (2013). Sumoylation: a regulatory protein modification in health and disease. Annu. Rev. Biochem. 82, 357-385. doi: 10.1146/annurev-biochem-061909-093311
49. Fu, J., Yu, H. M., Chiu, S. Y., Mirando, A. J., Maruyama, E. O., Cheng, J. G., et al. (2014). Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration. PLoS Genet. 10:e1004579. doi: 10.1371/journal.pgen.1004579
50. Fujita, E., Tanabe, Y., Shiota, A., Ueda, M., Suwa, K., Momoi, M. Y., et al. (2008). Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells. Proc. Natl. Acad. Sci. U S A 105, 3117-3122. doi: 10.1073/pnas.0712298105
51. Gardiner, K. (2006). Transcriptional dysregulation in down syndrome: predictions for altered protein complex stoichiometries and post-translational modifications and consequences for learning/behavior genes ELK, CREB and the estrogen and glucocorticoid receptors. Behav. Genet. 36, 439-453. doi: 10.1007/s10519-006-9051-1
52. Gareau, J. R., and Lima, C. D. (2010). The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861-871. doi: 10.1038/nrm3011
53. Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., et al. (2004). Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127-138. doi: 10.1016/j.cell.2004.06.018
54. Geiss-Friedlander, R., and Melchior, F. (2007). Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956. doi: 10.1038/nrm2293
55. Girach, F., Craig, T. J., Rocca, D. L., and Henley, J. M. (2013). RIM1a SUMOylation is required for fast synaptic vesicle exocytosis. Cell Rep. 5, 1294-1301. doi: 10.1016/j.celrep.2013.10.039
56. Glasscock, E., Qian, J., Yoo, J. W., and Noebels, J. L. (2007). Masking epilepsy by combining two epilepsy genes. Nat. Neurosci. 10, 1554-1558. doi: 10.1038/nn1999
57. Gowran, A., Murphy, C. E., and Campbell, V. A. (2009). Delta(9)-tetrahydrocannabinol regulates the p53 post-translational modifiers Murine double minute 2 and the small ubiquitin modifier protein in the rat brain. FEBS Lett. 583, 3412-3418. doi: 10.1016/j.febslet.2009.09.056
58. Grant, S. G. (2012). Synaptopathies: diseases of the synaptome. Curr. Opin. Neurobiol. 22, 522-529. doi: 10.1016/j.conb.2012.02.002
59. Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., et al. (2010). The angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704-716. doi: 10.1016/j.cell.2010.01.026
60. Grégoire, S., and Yang, X. J. (2005). Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25, 2273-2287. doi: 10.1128/mcb.25.6.2273-2287.2005
61. Grégoire, S., Tremblay, A. M., Xiao, L., Yang, Q., Ma, K., Nie, J., et al. (2006). Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281, 4423-4433. doi: 10.1074/jbc.m509471200
62. Grupe, A., Abraham, R., Li, Y., Rowland, C., Hollingworth, P., Morgan, A., et al. (2007). Evidence for novel susceptibility genes for late-onset alzheimer's disease from a genome-wide association study of putative functional variants. Hum. Mol. Genet. 16, 865-873. doi: 10.1093/hmg/ddm031
63. Guerrini, R., and Parrini, E. (2012). Epilepsy in rett syndrome and CDKL5-and FOXG1-gene-related encephalopathies. Epilepsia 53, 2067-2078. doi: 10.1111/j.1528-1167.2012.03656.x
64. Guo, C., Hildick, K. L., Luo, J., Dearden, L., Wilkinson, K. A., and Henley, J. M. (2013). SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia. EMBO J. 32, 1514-1528. doi: 10.1038/emboj.2013.65
65. Guo, D., Li, M., Zhang, Y., Yang, P., Eckenrode, S., Hopkins, D., et al. (2004). A functional variant of SUMO4, a new I κ B α modifier, is associated with type 1 diabetes. Nat. Genet. 36, 837-841. doi: 10.1038/ng1391
66. Gwizdek, C., Cassé, F., and Martin, S. (2013). Protein sumoylation in brain development, neuronal morphology and spinogenesis. Neuromolecular Med. 15, 677-691. doi: 10.1007/s12017-013-8252-z
67. Hackett, A., Tarpey, P. S., Licata, A., Cox, J., Whibley, A., Boyle, J., et al. (2010). CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes. Eur. J. Hum. Genet. 18, 544-552. doi: 10.1038/ejhg.2009.220
68. Hasegawa, Y., Yoshida, D., Nakamura, Y., and Sakakibara, S. (2014). Spatiotemporal distribution of SUMOylation components during mouse brain development. J. Comp. Neuro.l 522, 3020-3036. doi: 10.1002/cne.23563
69. Hay, R. T. (2005). SUMO: a history of modification. Mol. Cell 18, 1-12. doi: 10.1016/j.molcel.2005.03.012
70. Henley, J. M., Craig, T. J., and Wilkinson, K. A. (2014). Neuronal SUMOylation: mechanisms, physiology and roles in neuronal dysfunction. Physiol. Rev. 94, 1249-1285. doi: 10.1152/physrev.00008.2014
71. Hickey, C. M., Wilson, N. R., and Hochstrasser, M. (2012). Function and regulation of SUMO proteases. Nat. Rev. Mol. Cell Biol. 13, 755-766. doi: 10.1038/nrm3478
72. Hsueh, Y. P. (2006). The role of the MAGUK protein CASK in neural development and synaptic function. Curr. Med. Chem. 13, 1915-1927. doi: 10.2174/092986706777585040
73. Hsueh, Y. P. (2009). Calcium/calmodulin-dependent serine protein kinase and mental retardation. Ann. Neurol. 66, 438-443. doi: 10.1002/ana.21755
74. Huang, T. N., and Hsueh, Y. P. (2009). CASK point mutation regulates protein-protein interactions and NR2b promoter activity. Biochem. Biophys. Res. Commun. 382, 219-222. doi: 10.1016/j.bbrc.2009.03.015
75. Ip, J. P., Fu, A. K., and Ip, N. Y. (2014). CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. Neuroscientist 20, 589-598. doi: 10.1177/1073858413514278
76. Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., et al. (2010). Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 142, 387-397. doi: 10.1016/j.cell.2010.06.036
77. Jaafari, N., Konopacki, F. A., Owen, T. F., Kantamneni, S., Rubin, P., Craig, T. J., et al. (2013). SUMOylation is required for glycine-induced increases in AMPA receptor surface expression (ChemLTP) in hippocampal neurons. PLoS One 8:e52345. doi: 10.1371/journal.pone.0052345
78. Ju, W., Li, Q., Wilson, S. M., Brittain, J. M., Meroueh, L., and Khanna, R. (2013). SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons. Channels (Austin) 7, 153-159. doi: 10.4161/chan.24224
79. Kang, J., Gocke, C. B., and Yu, H. (2006). Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem. 7:5. doi: 10.1186/1471-2091-7-5
80. Karpinar, D. P., Balija, M. B., Kügler, S., Opazo, F., Rezaei-Ghaleh, N., Wender, N., et al. (2009). Pre-fibrillar a-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models. EMBO J. 28, 3256-3268. doi: 10.1038/emboj.2009.257
81. Kaufmann, W. E., and Moser, H. W. (2000). Dendritic anomalies in disorders associated with mental retardation. Cereb. Cortex 10, 981-991. doi: 10.1093/cercor/10.10.981
82. Kim, Y. M., Jang, W. H., Quezado, M. M., Oh, Y., Chung, K. C., Junn, E., et al. (2011). Proteasome inhibition induces a-synuclein SUMOylation and aggregate formation. J. Neurol. Sci. 307, 157-161. doi: 10.1016/j.jns.2011.04.015
83. Kneussel, M., and Hausrat, T. J. (2016). Postsynaptic neurotransmitter receptor reserve pools for synaptic potentiation. Trends Neurosci. 39, 170-182. doi: 10.1016/j.tins.2016.01.002
84. Kofuji, T., Fujiwara, T., Sanada, M., Mishima, T., and Akagawa, K. (2014). HPC-1/syntaxin 1A and syntaxin 1B play distinct roles in neuronal survival. J. Neurochem. 130, 514-525. doi: 10.1111/jnc.12722
85. Konopacki, F. A., Jaafari, N., Rocca, D. L., Wilkinson, K. A., Chamberlain, S., Rubin, P., et al. (2011). Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis. Proc. Natl. Acad. Sci. U S A 108, 19772-19777. doi: 10.1073/pnas.1111575108
86. Krumova, P., Meulmeester, E., Garrido, M., Tirard, M., Hsiao, H. H., Bossis, G., et al. (2011). Sumoylation inhibits a-synuclein aggregation and toxicity. J. Cell Biol. 194, 49-60. doi: 10.1083/jcb.201010117
87. Krumova, P., and Weishaupt, J. H. (2012). Sumoylation in neurodegenerative diseases. Cell. Mol. Life Sci. 70, 2123-2138. doi: 10.1007/s00018-012-1158-3
88. Kunadt, M., Eckermann, K., Stuendl, A., Gong, J., Russo, B., Strauss, K., et al. (2015). Extracellular vesicle sorting of a-Synuclein is regulated by sumoylation. Acta Neuropathol. 129, 695-713. doi: 10.1007/s00401-015-1408-1
89. Lai, C. S., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., and Monaco, A. P. (2001). A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413, 519-523. doi: 10.1038/35097076
90. Lai, C. S., Gerrelli, D., Monaco, A. P., Fisher, S. E., and Copp, A. J. (2003). FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder. Brain 126, 2455-2462. doi: 10.1093/brain/awg247
91. Lee, L., Dale, E., Staniszewski, A., Zhang, H., Saeed, F., Sakurai, M., et al. (2014). Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease. Sci. Rep. 4:7190. doi: 10.1038/srep07190
92. Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., and Fraser, P. (2013). SUMO and Alzheimer's disease. Neuromolecular Med. 15, 720-736. doi: 10.1007/s12017-013-8257-7
93. Li, H., Radford, J. C., Ragusa, M. J., Shea, K. L., McKercher, S. R., Zaremba, J. D., et al. (2008). Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc. Natl. Acad. Sci. U S A 105, 9397-9402. doi: 10.1073/pnas.0802876105
94. Li, Y., Wang, H., Wang, S., Quon, D., Liu, Y. W., and Cordell, B. (2003). Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc. Natl. Acad. Sci. U S A 100, 259-264. doi: 10.1073/pnas.0235361100
95. Loane, M., Morris, J. K., Addor, M. C., Arriola, L., Budd, J., Doray, B., et al. (2013). Twenty-year trends in the prevalence of down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur. J. Hum. Genet. 21, 27-33. doi: 10.1038/ejhg.2012.94
96. Loriol, C., Cassé, F., Khayachi, A., Poupon, G., Chafai, M., Deval, E., et al. (2014). mGlu5 receptors regulate synaptic sumoylation via a transient PKC-dependent diffusional trapping of Ubc9 into spines. Nat. Commun. 5:5113. doi: 10.1038/ncomms6113
97. Loriol, C., Khayachi, A., Poupon, G., Gwizdek, C., and Martin, S. (2013). Activity-dependent regulation of the sumoylation machinery in rat hippocampal neurons. Biol. Cell 105, 30-45. doi: 10.1111/boc.201200016
98. Loriol, C., Parisot, J., Poupon, G., Gwizdek, C., and Martin, S. (2012). Developmental regulation and spatiotemporal redistribution of the sumoylation machinery in the rat central nervous system. PLoS One 7:e33757. doi: 10.1371/journal.pone.0033757
99. Lu, H., Liu, B., You, S., Chen, L., Dongmei, Q., Gu, M., et al. (2013). SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner. Mol. Biol. Rep. 40, 2485-2490. doi: 10.1007/s11033-012-2329-x
100. Lu, H. C., and Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biol. Psychiatry 79, 516-525. doi: 10.1016/j.biopsych.2015.07.028
101. Lu, W., Man, H., Ju, W., Trimble, W. S., MacDonald, J. F., and Wang, Y. T. (2001). Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29, 243-254. doi: 10.1016/s0896-6273(01)00194-5
102. Luo, J., Ashikaga, E., Rubin, P. P., Heimann, M. J., Hildick, K. L., Bishop, P., et al. (2013). Receptor trafficking and the regulation of synaptic plasticity by SUMO. Neuromolecular Med. 15, 692-706. doi: 10.1007/s12017-013-8253-y
103. Luo, H. B., Xia, Y. Y., Shu, X. J., Liu, Z. C., Feng, Y., Liu, X. H., et al. (2014). SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc. Natl. Acad. Sci. U S A 111, 16586-16591. doi: 10.1073/pnas.1417548111
104. Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107. doi: 10.1016/s0092-8674(00)81862-0
105. Maraschi, A., Ciammola, A., Folci, A., Sassone, F., Ronzitti, G., Cappelletti, G., et al. (2014). Parkin regulates kainate receptors by interacting with the GluK2 subunit. Nat. Commun. 5:5182. doi: 10.1038/ncomms6182
106. Martin, S. (2009). Extranuclear functions of protein sumoylation in the central nervous system. Med. Sci. (Paris) 25, 693-698. doi: 10.1051/medsci/2009258-9693
107. Martin, S., and Henley, J. M. (2004). Activity-dependent endocytic sorting of kainate receptors to recycling or degradation pathways. EMBO J. 23, 4749-4759. doi: 10.1038/sj.emboj.7600483
108. Martin, S., Nishimune, A., Mellor, J. R., and Henley, J. M. (2007a). SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447, 321-325. doi: 10.1038/nature05736
109. Martin, S., Wilkinson, K. A., Nishimune, A., and Henley, J. M. (2007b). Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8, 948-959. doi: 10.1038/nrn2276
110. Matsuda, S., Launey, T., Mikawa, S., and Hirai, H. (2000). Disruption of AMPA receptor GluR2 clusters following long-term depression induction in cerebellar Purkinje neurons. EMBO J. 19, 2765-2774. doi: 10.1093/emboj/19.12.2765
111. Matsuzaki, S., Lee, L., Knock, E., Srikumar, T., Sakurai, M., Hazrati, L. N., et al. (2015). SUMO1 affects synaptic function, spine density and memory. Sci. Rep. 5:10730. doi: 10.1038/srep10730
112. Matunis, M. J., Coutavas, E., and Blobel, G. (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470. doi: 10.1083/jcb.135.6.1457
113. Meredith, L. J., Wang, C. M., Nascimento, L., Liu, R., Wang, L., and Yang, W. H. (2016). The key regulator for language and speech development, FOXP2, is a novel substrate for SUMOylation. J. Cell. Biochem. 117, 426-438. doi: 10.1002/jcb.25288
114. Mukhopadhyay, D., and Dasso, M. (2007). Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32, 286-295. doi: 10.1016/j.tibs.2007.05.002
115. Nakamura, K., Anitha, A., Yamada, K., Tsujii, M., Iwayama, Y., Hattori, E., et al. (2008). Genetic and expression analyses reveal elevated expression of syntaxin 1A ( STX1A) in high functioning autism. Int. J. Neuropsychopharmacol. 11, 1073-1084. doi: 10.1017/S1461145708009036
116. Nistico, R., Ferraina, C., Marconi, V., Blandini, F., Negri, L., Egebjerg, J., et al. (2014). Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease. Front. Pharmacol. 5:63. doi: 10.3389/fphar.2014.00063
117. Niswender, C. M., and Conn, P. J. (2010). Metabotropic glutamate receptors: physiology, pharmacology and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295-322. doi: 10.1146/annurev.pharmtox.011008.145533
118. Oh, Y., Kim, Y. M., Mouradian, M. M., and Chung, K. C. (2011). Human Polycomb protein 2 promotes a-synuclein aggregate formation through covalent SUMOylation. Brain Res. 1381, 78-89. doi: 10.1016/j.brainres.2011.01.039
119. O'Rourke, J. G., Gareau, J. R., Ochaba, J., Song, W., Raskó, T., Reverter, D., et al. (2013). SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation. Cell Rep. 4, 362-375. doi: 10.1016/j.celrep.2013.06.034
120. Pavlopoulos, E., Trifilieff, P., Chevaleyre, V., Fioriti, L., Zairis, S., Pagano, A., et al. (2011). Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage. Cell 147, 1369-1383. doi: 10.1016/j.cell.2011.09.056
121. Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., et al. (2015). a-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340-344. doi: 10.1038/nature14547
122. Perluigi, M., and Butterfield, D. A. (2012). Oxidative stress and down syndrome: a route toward Alzheimer-like dementia. Curr. Gerontol. Geriatr. Res. 2012:724904. doi: 10.1155/2012/724904
123. Plant, L. D., Dowdell, E. J., Dementieva, I. S., Marks, J. D., and Goldstein, S. A. (2011). SUMO modification of cell surface Kv2.1 potassium channels regulates the activity of rat hippocampal neurons. J. Gen. Physiol. 137, 441-454. doi: 10.1085/jgp.201110604
124. Pountney, D. L., Huang, Y., Burns, R. J., Haan, E., Thompson, P. D., Blumbergs, P. C., et al. (2003). SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp. Neurol. 184, 436-446. doi: 10.1016/j.expneurol.2003.07.004
125. Qi, Y., Wang, J., Bomben, V. C., Li, D. P., Chen, S. R., Sun, H., et al. (2014). Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death. Neuron 83, 1159-1171. doi: 10.1016/j.neuron.2014.07.042
126. Rashid, A. J., Cole, C. J., and Josselyn, S. A. (2014). Emerging roles for MEF2 transcription factors in memory. Genes Brain Behav. 13, 118-125. doi: 10.1111/gbb.12058
127. Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., et al. (2010). Deleterious effects of amyloid β oligomers acting as an extracellular scaffold for mGluR5. Neuron 66, 739-754. doi: 10.1016/j.neuron.2010.04.029
128. Riquelme, C., Barthel, K. K., and Liu, X. (2006). SUMO-1 modification of MEF2A regulates its transcriptional activity. J. Cell. Mol. Med. 10, 132-144. doi: 10.1111/j.1582-4934.2006.tb00295.x
129. Rodriguez, M. S., Dargemont, C., and Hay, R. T. (2001). SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659. doi: 10.1074/jbc.m009476200
130. Roper, R. J., and Reeves, R. H. (2006). Understanding the basis for down syndrome phenotypes. PLoS Genet. 2:e50. doi: 10.1371/journal.pgen.0020050
131. Ross, C. A., and Tabrizi, S. J. (2011). Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83-98. doi: 10.1016/s1474-4422(10)70245-3
132. Sampson, D. A., Wang, M., and Matunis, M. J. (2001). The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276, 21664-21669. doi: 10.1074/jbc.m100006200
133. Schulz, S., Chachami, G., Kozaczkiewicz, L., Winter, U., Stankovic-Valentin, N., Haas, P., et al. (2012). Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep. 13, 930-938. doi: 10.1038/embor.2012.125
134. Setou, M., Nakagawa, T., Seog, D. H., and Hirokawa, N. (2000). Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288, 1796-1802. doi: 10.1126/science.288.5472.1796
135. Shahpasandzadeh, H., Popova, B., Kleinknecht, A., Fraser, P. E., Outeiro, T. F., and Braus, G. H. (2014). Interplay between sumoylation and phosphorylation for protection against a-synuclein inclusions. J. Biol. Chem. 289, 31224-31240. doi: 10.1074/jbc.M114.559237
136. Shalizi, A., Bilimoria, P. M., Stegmüller, J., Gaudillière, B., Yang, Y., Shuai, K., et al. (2007). PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis. J. Neurosci. 27, 10037-10046. doi: 10.1523/jneurosci.0361-07.2007
137. Shalizi, A., Gaudillière, B., Yuan, Z., Stegmuller, J., Shirogane, T., Ge, Q., et al. (2006). A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311, 1012-1017. doi: 10.1126/science.1122513
138. Shin, E. J., Shin, H. M., Nam, E., Kim, W. S., Kim, J. H., Oh, B. H., et al. (2012). DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep. 13, 339-346. doi: 10.1038/embor.2012.3
139. Shinbo, Y., Niki, T., Taira, T., Ooe, H., Takahashi-Niki, K., Maita, C., et al. (2006). Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ. 13, 96-108. doi: 10.1038/sj.cdd.4401704
140. Shukkur, E. A., Shimohata, A., Akagi, T., Yu, W., Yamaguchi, M., Murayama, M., et al. (2006). Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for down syndrome. Hum. Mol. Genet. 15, 2752-2762. doi: 10.1093/hmg/ddl211
141. Si, K., Choi, Y. B., White-Grindley, E., Majumdar, A., and Kandel, E. R. (2010). Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140, 421-435. doi: 10.1016/j.cell.2010.01.008
142. Simón, A. M., Schiapparelli, L., Salazar-Colocho, P., Cuadrado-Tejedor, M., Escribano, L., Lopez De Maturana, R., et al. (2009). Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels. Neurobiol. Dis. 33, 369-378. doi: 10.1016/j.nbd.2008.11.005
143. Spires-Jones, T. L., Friedman, T., Pitstick, R., Polydoro, M., Roe, A., Carlson, G. A., et al. (2014). Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy. Neurosci. Lett. 562, 63-68. doi: 10.1016/j.neulet.2014.01.013
144. Spires-Jones, T. L., and Hyman, B. T. (2014). The intersection of amyloid β and tau at synapses in Alzheimer's disease. Neuron 82, 756-771. doi: 10.1016/j.neuron.2014.05.004
145. Stavraka, C., and Blagden, S. (2015). The La-related proteins, a family with connections to cancer. Biomolecules 5, 2701-2722. doi: 10.3390/biom5042701
146. Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L. C., Slepko, N., et al. (2004). SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104. doi: 10.1126/science.1092194
147. Subramaniam, S., Sixt, K. M., Barrow, R., and Snyder, S. H. (2009). Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330. doi: 10.1126/science.1172871
148. Südhof, T. C. (2013). Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80, 675-690. doi: 10.1016/j.neuron.2013.10.022
149. Südhof, T. C., and Rizo, J. (2011). Synaptic vesicle exocytosis. Cold Spring Harb. Perspect. Biol. 3:a005637. doi: 10.1101/cshperspect.a005637
150. Tai, D. J., Liu, Y. C., Hsu, W. L., Ma, Y. L., Cheng, S. J., Liu, S. Y., et al. (2016). MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of rett syndrome. Nat. Commun. 7:10552. doi: 10.1038/ncomms10552
151. Tai, H. C., Serrano-Pozo, A., Hashimoto, T., Frosch, M. P., Spires-Jones, T. L., and Hyman, B. T. (2012). The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer's disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 181, 1426-1435. doi: 10.1016/j.ajpath.2012.06.033
152. Takahashi, K., Ishida, M., Komano, H., and Takahashi, H. (2008). SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice. Neurosci. Lett. 441, 90-93. doi: 10.1016/j.neulet.2008.06.012
153. Tang, L. T., Craig, T. J., and Henley, J. M. (2015). SUMOylation of synapsin Ia maintains synaptic vesicle availability and is reduced in an autism mutation. Nat. Commun. 6:7728. doi: 10.1038/ncomms8728
154. Tang, Z., El Far, O., Betz, H., and Scheschonka, A. (2005). Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. J. Biol. Chem. 280, 38153-38159. doi: 10.1074/jbc.m508168200
155. Tao, X., and Tong, L. (2003). Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J. Biol. Chem. 278, 31372-31379. doi: 10.1074/jbc.m304221200
156. Tirard, M., Hsiao, H. H., Nikolov, M., Urlaub, H., Melchior, F., and Brose, N. (2012). In vivo localization and identification of SUMOylated proteins in the brain of His6-HA-SUMO1 knock-in mice. Proc. Natl. Acad. Sci. U S A 109, 21122-21127. doi: 10.1073/pnas.1215366110
157. Turrigiano, G. G. (2008). The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135, 422-435. doi: 10.1016/j.cell.2008.10.008
158. Um, J. W., and Chung, K. C. (2006). Functional modulation of parkin through physical interaction with SUMO-1. J. Neurosci. Res. 84, 1543-1554. doi: 10.1002/jnr.21041
159. Usami, Y., Hatano, T., Imai, S., Kubo, S., Sato, S., Saiki, S., et al. (2011). DJ-1 associates with synaptic membranes. Neurobiol. Dis. 43, 651-662. doi: 10.1016/j.nbd.2011.05.014
160. Usui, N., Co, M., Harper, M., Rieger, M. A., Dougherty, J. D., and Konopka, G. (2016). Sumoylation of FOXP2 regulates motor function and vocal communication through Purkinje cell development. Biol. Psychiatry doi: 10.1016/j.biopsych.2016.02.008 [Epub ahead of print].
161. van Niekerk, E. A., Willis, D. E., Chang, J. H., Reumann, K., Heise, T., and Twiss, J. L. (2007). Sumoylation in axons triggers retrograde transport of the RNA-binding protein La. Proc. Natl. Acad. Sci. U S A 104, 12913-12918. doi: 10.1073/pnas.0611562104
162. van Spronsen, M., and Hoogenraad, C. C. (2010). Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep. 10, 207-214. doi: 10.1007/s11910-010-0104-8
163. Velier, J., Kim, M., Schwarz, C., Kim, T. W., Sapp, E., Chase, K., et al. (1998). Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol. 152, 34-40. doi: 10.1006/exnr.1998.6832
164. Vijayakumaran, S., Wong, M. B., Antony, H., and Pountney, D. L. (2015). Direct and/or indirect roles for SUMO in modulating a-synuclein toxicity. Biomolecules 5, 1697-1716. doi: 10.3390/biom5031697
165. Wang, Y., Chandran, J. S., Cai, H., and Mattson, M. P. (2008). DJ-1 is essential for long-term depression at hippocampal CA1 synapses. Neuromolecular Med. 10, 40-45. doi: 10.1007/s12017-008-8023-4
166. Wang, L., Ma, Q., Yang, W., Mackensen, G. B., and Paschen, W. (2012). Moderate hypothermia induces marked increase in levels and nuclear accumulation of SUMO2/3-conjugated proteins in neurons. J. Neurochem. 123, 349-359. doi: 10.1111/j.1471-4159.2012.07916.x
167. Wang, L., Wansleeben, C., Zhao, S., Miao, P., Paschen, W., and Yang, W. (2014). SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development. EMBO Rep. 15, 878-885. doi: 10.15252/embr.201438534
168. Watanabe, Y., Katayama, N., Takeuchi, K., Togano, T., Itoh, R., Sato, M., et al. (2013). Point mutation in syntaxin-1A causes abnormal vesicle recycling, behaviors and short term plasticity. J. Biol. Chem. 288, 34906-34919. doi: 10.1074/jbc.M113.504050
169. Watanabe, M., Takahashi, K., Tomizawa, K., Mizusawa, H., and Takahashi, H. (2008). Developmental regulation of Ubc9 in the rat nervous system. Acta Biochim. Pol. 55, 681-686.
170. Weeraratna, A. T., Kalehua, A., Deleon, I., Bertak, D., Maher, G., Wade, M. S., et al. (2007). Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp. Cell Res. 313, 450-461. doi: 10.1016/j.yexcr.2006.10.028
171. Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schafer, C., Rammner, B., et al. (2014). Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344, 1023-1028. doi: 10.1126/science.1252884
172. Wilkinson, K. A., and Henley, J. M. (2011). Analysis of metabotropic glutamate receptor 7 as a potential substrate for SUMOylation. Neurosci. Lett. 491, 181-186. doi: 10.1016/j.neulet.2011.01.032
173. Wilkinson, K. A., Nishimune, A., and Henley, J. M. (2008). Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs. Neurosci. Lett. 436, 239-244. doi: 10.1016/j.neulet.2008.03.029
174. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., et al. (2011). In vivo demonstration that a-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. U S A 108, 4194-4199. doi: 10.1073/pnas.1100976108
175. Wu, H., Chen, X., Cheng, J., and Qi, Y. (2016). SUMOylation and potassium channels: links to epilepsy and sudden death. Adv. Protein Chem. Struct. Biol. 103, 295-321. doi: 10.1016/bs.apcsb.2015.11.009
176. Yamada, T., Yang, Y., Huang, J., Coppola, G., Geschwind, D. H., and Bonni, A. (2013). Sumoylated MEF2A coordinately eliminates orphan presynaptic sites and promotes maturation of presynaptic boutons. J. Neurosci. 33, 4726-4740. doi: 10.1523/JNEUROSCI.4191-12.2013
177. Yin, Y., She, H., Li, W., Yang, Q., Guo, S., and Mao, Z. (2012). Modulation of neuronal survival factor MEF2 by kinases in Parkinson's disease. Front. Physiol. 3:171. doi: 10.3389/fphys.2012.00171
178. Yokoi, N., Fukata, M., and Fukata, Y. (2012). Synaptic plasticity regulated by protein-protein interactions and posttranslational modifications. Int. Rev. Cell Mol. Biol. 297, 1-43. doi: 10.1016/b978-0-12-394308-8.00001-7
179. Yun, S. M., Cho, S. J., Song, J. C., Song, S. Y., Jo, S. A., Jo, C., et al. (2013). SUMO1 modulates Aβ generation via BACE1 accumulation. Neurobiol. Aging 34, 650-662. doi: 10.1016/j.neurobiolaging.2012.08.005
180. Zeitlin, S., Liu, J. P., Chapman, D. L., Papaioannou, V. E., and Efstratiadis, A. (1995). Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11, 155-163. doi: 10.1038/ng1095-155
181. Zhang, Y. Q., and Sarge, K. D. (2008). Sumoylation of amyloid precursor protein negatively regulates Aβ aggregate levels. Biochem. Biophys. Res. Commun. 374, 673-678. doi: 10.1016/j.bbrc.2008.07.109
182. Zhao, X., Sternsdorf, T., Bolger, T. A., Evans, R. M., and Yao, T. P. (2005). Regulation of MEF2 by histone deacetylase 4-and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell. Biol. 25, 8456-8464. doi: 10.1128/mcb.25.19.8456-8464.2005
183. Zhu, Q. J., Xu, Y., Du, C. P., and Hou, X. Y. (2012). SUMOylation of the kainate receptor subunit GluK2 contributes to the activation of the MLK3-JNK3 pathway following kainate stimulation. FEBS Lett. 586, 1259-1264. doi: 10.1016/j.febslet.2012.03.048
184. Zuberi, S. M., Eunson, L. H., Spauschus, A., De Silva, R., Tolmie, J., Wood, N. W., et al. (1999). A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122, 817-825. doi: 10.1093/brain/122.5.817